Globus Medical to buy neurostim developer Nevro for $250M - Fierce Biotech
The company's full annual accounting is scheduled for February 20. Related. Nevro nabs FDA approval for spinal cord stimulator that uses AI to …
Fierce Biotech 8
Covers: HealthcareGovernment & Public SectorAI Safety & Existential RiskRegulation & PolicyBias & Fairness
Trump cancels Biden executive order on AI safety - Fierce Biotech
Among his first actions as president, Trump rescinded an order that directed the U.S. government to develop safeguards for AI programs …
Health tech firm Carta Healthcare buys AI company that matches patients to cancer trials
Fierce Biotech ... that uses AI to match patients to clinical trials. Realyze uses clinician-trained AI to scour data in electronic health records and pair patients …
Precise Dx's digital pathology AI on par with genomic testing in predicting breast cancer ...
Fierce Biotech The company—born out of digital pathology work at Mount Sinai Health System—said it aims to categorize patients at either high or lowriskfor …
Merck bags options on Evaxion's AI-designed vaccine candidates - Fierce Biotech
The deal covers two candidates derived from an Evaxion technology that uses AI to identify antigens that can trigger robust, protective immune …
HowAIAccelerates Clinical & Drug Development Timelines | Fierce Biotech
Yet, as we harness this potent technology, therisksof AI bias loom large, posing seriousthreatsto research integrity and patient safety. In this …
Study shows generative AI can speed up clinical trial enrollment for pennies per patient
Fierce Biotech...AI-focused publication. However, the researchers noted that employing AI can bringrisks—such as introducing or reinforcing ethnic or racial …
FDA approves first genetic test to screen for opioid use disorderrisks- Fierce Biotech
Fierce Biotech'Explainable'AI discovers new class of antibiotics that stop MRSA in mice. Dec 20, 2023 04:25pm. Passage looks to offload lead program, 2 other …